Perceval
Device Cardiology/Vascular Diseases
General payments
$922,656
Research payments
$1,045,923
Through program year 2021, $922,656 in general payments and $1,045,923 in research payments were reported against Perceval (Cardiology/Vascular Diseases).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $10,900 | 6 |
| 2021 | Research | $1,700 | 2 |
| 2020 | General | $147,044 | 290 |
| 2020 | Research | $277,409 | 94 |
| 2019 | General | $764,712 | 1,417 |
| 2019 | Research | $766,814 | 129 |
Breakdown
Each share is of general payments naming this product in 2021.
Each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2021 where a state was reported.
Records
1,713 general · 225 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.